Short Information | Xilio Therapeutics Inc. (NASDAQ:XLO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 842,566 |
Total Actual Volume | 9,987,450 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 1 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 42,128 |
Average Short Percentage | 27.28% |
Is there a XLO Short Squeeze or Breakout about to happen?
See the XLO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.95 | $0.89 | $0.959999 | $0.86 | 366,297 | 161,960 | 44.22% |
07-01-2024 | $0.9291 | $0.9239 | $0.9599 | $0.897 | 123,322 | 27,964 | 22.68% |
06-28-2024 | $0.95 | $0.9475 | $0.96 | $0.89 | 139,796 | 42,030 | 30.07% |
06-27-2024 | $0.89 | $0.94 | $0.9699 | $0.89 | 47,187 | 23,882 | 50.61% |
06-26-2024 | $0.949799 | $0.9121 | $0.949799 | $0.904 | 54,772 | 16,992 | 31.02% |
06-25-2024 | $0.95 | $0.9001 | $0.9501 | $0.9001 | 183,109 | 59,756 | 32.63% |
06-24-2024 | $0.9 | $0.9308 | $0.9525 | $0.8605 | 66,214 | 19,989 | 30.19% |
06-21-2024 | $0.9401 | $0.9084 | $0.9401 | $0.852222 | 476,685 | 108,826 | 22.83% |
06-20-2024 | $0.95 | $0.9536 | $1.02 | $0.930101 | 85,270 | 37,989 | 44.55% |
06-18-2024 | $0.95 | $0.9469 | $0.9926 | $0.94 | 96,975 | 29,480 | 30.4% |
06-17-2024 | $1.02 | $0.95 | $1.02 | $0.94 | 199,360 | 56,725 | 28.45% |
06-14-2024 | $1.02 | $1.02 | $1.05 | $1.02 | 45,660 | 12,170 | 26.65% |
06-13-2024 | $1.08 | $1.05 | $1.08 | $1.01 | 118,670 | 19,328 | 16.29% |
06-12-2024 | $1.13 | $1.06 | $1.14 | $1.05 | 143,981 | 13,711 | 9.52% |
06-11-2024 | $1.09 | $1.12 | $1.13 | $1.05 | 113,232 | 20,895 | 18.45% |
06-10-2024 | $1.04 | $1.06 | $1.125 | $1.04 | 154,359 | 54,281 | 35.17% |
06-07-2024 | $1.04 | $1.05 | $1.06 | $0.98 | 7,175,939 | 47,081 | 0.66% |
06-06-2024 | $1.01 | $1.02 | $1.0699 | $1 | 103,113 | 35,447 | 34.38% |
06-05-2024 | $1.04 | $1.02 | $1.07 | $0.9802 | 169,160 | 31,669 | 18.72% |
06-04-2024 | $1.05 | $1.08 | $1.1 | $1.05 | 124,349 | 22,391 | 18.01% |
News, Short Squeeze, Breakout and More Instantly...
Xilio Therapeutics Inc. Company Name:
XLO Stock Symbol:
NASDAQ Market:
Xilio Therapeutics Inc. Website:
WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the appointment of Aoife Brennan, M.D., and James Sh...
Expect to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer (MSS CRC) in the third quarter of 2024 Plan to report clinical data for XTX101 and XTX301, a tumor-a...